bf/NASDAQ:LUNG_icon.jpeg

NASDAQ:LUNG

Pulmonx

  • Stock

3.77

−21.95%

2.17

USD last updated 19/08 02:06:19

Last Close

1.60

18/08 20:00

Market Cap

246.48M

Beta: 0.32

Volume Today

1.55M

Avg: 503.90K

PE Ratio

−8.91

PFCF: −17.91

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console syst...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -5-4-3-2-12019-03-302020-06-292022-05-032024-02-212024-11-042025-10-28

    Revenue (Estimate*)

    10M20M30M40M50M60M70M2019-03-302020-06-292022-05-032024-02-212024-11-042025-10-28

    *Estimate based on analyst consensus